New Lancet Commission calls for urgent action to tackle Europe's rising liver disease burden Every day in Europe, nearly 780 people die from cirrhosis or liver cancer — conditions that are largely preventable. A major new report from the EASL–Lancet Commission on…
The EASL General Assembly will take place on Friday, 29 May 2026, from 18:45 to 20:00 during EASL Congress 2026 in Barcelona. The meeting will be held in person in the Mondelli Room. Please note that an active EASL Membership…
We invite you to complete this short Consensus Survey in preparation for the MICROB-PREDICT Consensus Conference on Wednesday, 27 May 2026, during EASL Congress in Barcelona, Spain. Scope: Microbiome-based mechanisms and biomarkers for improved patient stratification and prediction of therapeutic response in decompensated…
The EASL community is deeply saddened by the loss of Dr Ahmed Elsharkawy, consultant transplant hepatologist, researcher, educator, and valued member of the EASL Governing Board. Ahmed served on the EASL Governing Board as EASL Internal Affairs Councillor from November…
Consistent and permanent abstinence from alcohol can lead to the regression of existing liver-related complications, even in cases of advanced alcohol-related cirrhosis. This is shown by an international multicenter study led by MedUni Vienna, which was recently published in the…
We’re proud to share a major milestone for the A-TANGO Consortium: the latest publication is now available in the Journal of Hepatology: Highlights of this important publication: This study in global cohorts of patients with acute decompensation of cirrhosis aimed…
Geneva, 18 February 2026 – The European Association for the Study of the Liver (EASL) has called on WHO Member States to support a landmark World Health Organization (WHO) draft resolution, “Steatotic Liver Disease – A Missing Piece in the…
EASL invites you to watch this on-demand webinar bringing together leading experts from across Europe to explore why early detection of chronic liver disease must become a priority in primary care. Through real-world experiences, the panel discusses how primary care…
THRIVE ACTIVITIES AT EASL LIVER CANCER SUMMIT 2026 The overall aim of the THRIVE project is to improve the outcome of both paediatric and adult liver cancer patients by understanding at-risk populations, tumour-host molecular interactions, developing biomarkers for current…
Are you deeply engaged in hepatology and science and ready to get involved in EASL’s governance? EASL is now looking to fill the following position: One Nurses & Allied Health Professionals (AHPs) Task Force Member To apply, please connect to the Member Zone.